David DeNardo, PhD, alongside his research team in the Tumor Immunology Program at Washington University School of Medicine, is working to understand why responses to cancer immunotherapy vary among patients.
David DeNardo, PhD Explores How the Tumor Microenvironment Affects Immune Responses to Cancer (Links to an external site)
